News Archives

  • Living longer and better after cancer

    June 12, 2020
    Clinical trials play a vital role in advancing cancer treatment at Kaiser Permanente, improving patients’ survival and quality of life. “Until the day that cancer is cured, there’s always room for improvement,” said Helen Moon, MD, a hematologist and oncologist at the Kaiser Permanente Riverside Medical Center. Helping to achieve that improvement is Dr. Moon’s role as ...
    Read more...
  • Exploring links between childhood maltreatment, epigenetics, and mental health

    May 28, 2020
    Researchers at Kaiser Permanente Southern California and the University of Southern California are teaming up on a new research project to better understand the relationship between child maltreatment, epigenetics, and mental health. Sonya Negriff, PhD, a developmental psychologist with Kaiser Permanente Southern California’s Department of Research & Evaluation, will lead the study along with Ferol Mennen, ...
    Read more...
  • Better screening for latent tuberculosis

    May 26, 2020
    Investigators in Kaiser Permanente Southern California and Kaiser Permanente Northern California have kicked off a new research project to develop better screening for latent tuberculosis. The project, led by Sara Tartof, PhD, MPH, an infectious disease epidemiologist with the Southern California Department of Research & Evaluation, is funded by the National Institute of Allergy and ...
    Read more...
  • 5 questions for … Dr. Deborah Cohen

    May 20, 2020
    Deborah A. Cohen, MD, MPH, an international expert on the health benefit of parks, is the newest scientist at the Department of Research & Evaluation. She began working in the department’s Division of Behavioral Research in January. She previously worked as a senior physician policy researcher at the RAND Corporation. She has served on panels for ...
    Read more...
  • Launching a multisite clinical trial in the midst of a pandemic

    May 19, 2020
    In early March 2020, as it became clear the novel coronavirus was closing in on Southern California, clinical trials leaders from the Department of Research & Evaluation began assessing options for an investigational treatment that could be studied through clinical trials. With no approved medications to fight COVID-19, the need for an investigational option to ...
    Read more...
  • Advancing treatments through clinical trials

    May 19, 2020
    Kaiser Permanente’s clinical trials program helps advance treatment for health conditions ranging from heart disease and cancer to infectious diseases, such as HIV and COVID-19. William Towner, MD, FACP, FIDSA, physician director for clinical trials at Kaiser Permanente Southern California, has seen firsthand how clinical trials can contribute to the development of more effective and safer ...
    Read more...
  • Stroke program integrates clinical trials

    May 17, 2020
    At Kaiser Permanente Southern California, physicians and researchers have been transforming stroke care, from simply treating the patients to also enrolling those not helped by the standard care into a clinical trials program, which expands the treatment options. “Our stroke program shows how Kaiser Permanente is invested in growing our clinical care through clinical trials,” said ...
    Read more...
  • English and non-English speakers get equal treatment in emergency departments

    May 17, 2020
    Kaiser Permanente Southern California researchers set out to understand the importance of emergency department patients and physicians speaking the same language by looking at the health outcomes and quality of care for patients with chest pain. They hypothesized that patients speaking a different language than their physician may have worse outcomes. They were happy to find ...
    Read more...